# Daptomycin

NDC: 70594-066
Generic name: daptomycin
Labeler / Manufacturer: Xellia Pharmaceuticals USA LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20231103

FDA application: NDA217415

## Active ingredients

- DAPTOMYCIN: 350 mg/7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70594-066"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70594-066
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e1f739a-eb81-43d8-9a14-89f32b7e1ba1